These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3589702)

  • 1. Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
    Leavitt RD; Ratanatharathorn V; Ozer H; Ultmann JE; Portlock C; Myers JW; Kisner D; Norred S; Spiegel RJ; Bonnem EM
    Semin Oncol; 1987 Jun; 14(2 Suppl 2):18-23. PubMed ID: 3589702
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the management of Hodgkin's and non-Hodgkin's lymphoma.
    Davis TA; Horning SJ
    Curr Opin Hematol; 1998 Jul; 5(4):259-63. PubMed ID: 9747632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
    Chisesi T; Capnist G; Vespignani M; Dini E
    Cancer Treat Rev; 1988 Jan; 15 Suppl A():27-33. PubMed ID: 2963691
    [No Abstract]   [Full Text] [Related]  

  • 4. Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
    Rohatiner AZ; Richards MA; Barnett MJ; Stansfeld AG; Lister TA
    Br J Cancer; 1987 Feb; 55(2):225-6. PubMed ID: 3814493
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin's disease.
    Schenkein DP; Dixon P; Desforges JF; Berkman E; Erban JK; Ascensao JL; Miller KB
    J Clin Oncol; 1994 Nov; 12(11):2423-31. PubMed ID: 7964959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial.
    Horning SJ; Merigan TC; Krown SE; Gutterman JU; Louie A; Gallagher J; McCravey J; Abramson J; Cabanillas F; Oettgen H
    Cancer; 1985 Sep; 56(6):1305-10. PubMed ID: 4027869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma.
    VanderMolen LA; Steis RG; Duffey PL; Foon KA; Smith JW; Clark JW; Conlon K; Stevenson HC; Urba WJ; Hartmann LC
    J Natl Cancer Inst; 1990 Feb; 82(3):235-8. PubMed ID: 2296053
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma.
    Chisesi T; Capnist G; Vespignani M; Cetto G
    Invest New Drugs; 1987; 5 Suppl():S35-40. PubMed ID: 3298132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon therapy of non-Hodgkin's lymphoma.
    Foon KA; Roth MS; Bunn PA
    Cancer; 1987 Feb; 59(3 Suppl):601-4. PubMed ID: 3492259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma.
    Smalley RV; Andersen JW; Hawkins MJ; Bhide V; O'Connell MJ; Oken MM; Borden EC
    N Engl J Med; 1992 Nov; 327(19):1336-41. PubMed ID: 1406835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostics, classification and high dose chemotherapy in non Hodgkin's and Hodgkin's lymphoma].
    Nowak WS; Jurczak W; Wójcik M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():73-9. PubMed ID: 10494187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy and immunocorrection in the programmed treatment of hemoblastoses in children].
    Makhonova LA
    Gematol Transfuziol; 1984 Feb; 29(2):3-6. PubMed ID: 6546729
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive immunotherapy for Hodgkin's lymphoma.
    Kennedy-Nasser AA; Bollard CM; Rooney CM
    Int J Hematol; 2006 Jun; 83(5):385-90. PubMed ID: 16787867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood and bone marrow transplantation for patients with Hodgkin's and non-Hodgkin's lymphoma.
    Flinn IW; Berdeja JG
    Cancer Treat Res; 2006; 131():251-81. PubMed ID: 16704172
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival in advanced Hodgkin's disease and non-Hodgkin's lymphoma.
    Rubin AD; Tadros G; Hanley D; Rubin GH; Todd D
    N J Med; 1996 Oct; 93(10):33-8. PubMed ID: 8918134
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon.
    Martino S; Ratanatharathorn V; Karanes C; Samal BA; Sohn YH; Rudnick SA
    J Cancer Res Clin Oncol; 1987; 113(4):376-8. PubMed ID: 3597523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1:2,3:4-Diepoxybutane in the treatment of Hodgkin's disease and lymphoreticulosarcoma.
    BICHEL J; STENDERUP A; JENSEN KB
    Acta Unio Int Contra Cancrum; 1960; 16():503-7. PubMed ID: 13848084
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation treatment of leukemias, Hodgkin's disease and lymphosarcoma.
    PEAKE JD; ESKRIDGE M
    Miss Valley Med J; 1951 Nov; 73(6):189-92. PubMed ID: 14882241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radioactive arsenic in treatment of Hodgkin's disease and mycosis fungoides].
    MALLET L; MARCHAL G; DUHAMEL G
    Acta Haematol; 1952 Jan; 7(1):27-38. PubMed ID: 14902321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.